Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Assets: 2018-2021

Historic Assets for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $274.1 million.

  • Black Diamond Therapeutics' Assets fell 20.87% to $274.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $274.1 million, marking a year-over-year decrease of 20.87%. This contributed to the annual value of $329.7 million for FY2020, which is 108.26% up from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Assets is $274.1 million, which was down 4.78% from $287.9 million recorded in Q2 2021.
  • Black Diamond Therapeutics' Assets' 5-year high stood at $362.8 million during Q1 2020, with a 5-year trough of $51.8 million in Q4 2018.
  • In the last 3 years, Black Diamond Therapeutics' Assets had a median value of $321.5 million in 2020 and averaged $302.7 million.
  • In the last 5 years, Black Diamond Therapeutics' Assets spiked by 205.44% in 2019 and then declined by 20.87% in 2021.
  • Quarterly analysis of 4 years shows Black Diamond Therapeutics' Assets stood at $51.8 million in 2018, then soared by 205.44% to $158.3 million in 2019, then surged by 108.26% to $329.7 million in 2020, then declined by 20.87% to $274.1 million in 2021.
  • Its Assets was $274.1 million in Q3 2021, compared to $287.9 million in Q2 2021 and $313.3 million in Q1 2021.